David Berman has been appointed Director, Queen's Cancer Research Institute

Posted 2015 March 04

David Berman has been appointed Director, Queen's Cancer Research Institute for an initial term from January 1, 2015 to June 30, 2020. Dr. Berman succeeds Dr. Roger Deeley who has held the appointment since August 1, 2003. This appointment is made by Alan Harrison, Provost and Vice-Principal (Academic) on the recommendation of Richard Reznick, Dean of the Faculty of Health Sciences.

Dr. Berman obtained his Bachelor of Arts in psychology in 1983 and completed a combined MD/PhD at University of Texas Southwestern Medical School in 1996. This was followed by a residency at Johns Hopkins Hospital where he served as Chief Resident from 1998 to 1999. Subsequently, Dr. Berman completed a postdoctoral fellowship in molecular biology and genetics/pathology at Johns Hopkins University.

Dr. Berman joined the Department of Pathology at Johns Hopkins University in 2001 as an instructor, and in 2002 he became an Assistant Professor of Pathology, Urology and Oncology. In 2008 he was promoted to the rank of Associate Professor. In 2012, Dr. Berman joined the Department of Pathology and Molecular Medicine at Queen's University as an Associate Professor and was promoted to Professor in 2014.

Dr. Berman's involvement in graduate and medical education is extensive, and he has provided mentorship and supervision to numerous undergraduate and graduate students, resident physicians, postdoctoral fellows and junior faculty. In his time at Johns Hopkins Medical Institutions, he served as Director of Curriculum for the Pathobiology Graduate Program and Director of the Career Development and Advising Program for Pathology Residents. In 2008, he was chosen as one of 20 'Master Mentors' to participate in an ongoing campus-wide mentorship program. At Queen's, Dr. Berman serves as Director of resident research for the Department of Pathology and Molecular Medicine, and he currently Chairs the Advanced Diagnostics Section for the Canadian Association of Pathologists.

A clinician scientist at Kingston General Hospital and Queen's University, Dr. Berman is an expert in bladder and prostate cancer diagnosis. His research focuses on developing novel diagnostic strategies for prostate and bladder cancer. He has over 50 peer-reviewed publications, has led/co-led over 15 peer-reviewed grant-funded studies

berman2015mar